Company: JUSHF
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001628280-25-037797
Chunk: 52

Company: Jushi Holdings Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Item 8
Chunk 52
---
BTThe components of the Company’s debt are as follows:Effective Interest RateMaturity DateJune 30, 2025 (unaudited)December 31, 2024Principal amounts:Second Lien Notes17%December 2026$86,209 $80,131 Term Loans26%September 2026 (1)48,500 48,500 Acquisition-related promissory notes payable8% - 14%October 2025 - April 202728,512 22,289 Mortgage loans6% - 10%January 2027 - April 202828,759 29,054 Total debt subject to scheduled repayments191,980 179,974 Promissory notes payable to Sammartino (2)10%September 2024 - September 202621,500 21,500 Total debt213,480 201,474 Less: debt issuance costs and original issue discounts(13,566)(15,267)Total debt, net$199,914 $186,207 Debt, net - current portion$7,088 $2,758 Debt, net - non-current portion$192,826 $183,449 (1)Matures the earlier of (a) January 31, 2027 and (b) the date that is 91 days prior to the final maturity of the Second Lien Notes. The Second Lien Notes are set to mature December 2026.(2)This amount is related to the promissory notes issued to Sammartino Investments LLC (“Sammartino”) in connection with the acquisition of Nature's Remedy of Massachusetts, Inc. (“Nature's Remedy”) in September 2021. The Company currently has no obligation to pay the principal and interest. See further discussion of the Sammartino Matter in Note 16 - Commitments and Contingencies for more information.Second Lien NotesIn February 2025, the Company issued US$3,719 principal amount of 12% second lien notes due 2026 (“Second Lien Notes”) and C$2,000 principal amount of Second Lien Notes. The issuances of the Second Lien Notes were also accompanied by 8,010,626 five-year detached warrants to purchase the Company’s subordinate voting shares, no par value per share, in a private placement at a strike price of US$0.48 per subordinate voting share.An entity affiliated with James